Brevan Howard Capital Management’s Geron GERN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$39.9K Sell
31,173
-7,650
-20% -$10.8K ﹤0.01% 2023
2026
Q1
$57.8K Sell
38,823
-5,790
-13% -$8.8K ﹤0.01% 2076
2025
Q4
$58.9K Sell
44,613
-224,915
-83% -$282K ﹤0.01% 1695
2025
Q3
$369K Buy
269,528
+233,911
+657% +$311K ﹤0.01% 1444
2025
Q2
$50.2K Sell
35,617
-89,782
-72% -$127K ﹤0.01% 1808
2025
Q1
$199K Buy
+125,399
New +$305K ﹤0.01% 989
2024
Q3
– Sell
-75,143
Closed -$319K – 1247
2024
Q2
$319K Buy
+75,143
New +$293K ﹤0.01% 754

Other funds holding GERN

Brevan Howard Capital Management's GERN Position: Q2 2026 in Review

Brevan Howard Capital Management reduced its Geron (GERN) stake by 20% in Q2 2026, selling an estimated $10.8K and leaving 31,173 shares worth $39.9K. The position accounts for ﹤0.01% of the portfolio, ranked #2023.

Brevan Howard Capital Management first reported a position in GERN in Q2 2024 and has held it in 7 quarters since. The position peaked at $369K in Q3 2025. 260 funds tracked by Wall St. Rank hold GERN as of Q2 2026.

  • Brevan Howard Capital Management held 31,173 shares of Geron worth $39.9K as of Q2 2026.
  • Brevan Howard Capital Management sold 7,650 Geron shares in Q2 2026, an estimated $10.8K.
  • Geron made up ﹤0.01% of Brevan Howard Capital Management's portfolio in Q2 2026, its #2023 holding.
  • Brevan Howard Capital Management first reported a position in Geron in Q2 2024 and has held it in 7 quarters since.
  • Brevan Howard Capital Management's Geron position peaked at $369K in Q3 2025.
  • 260 funds tracked by Wall St. Rank held Geron as of Q2 2026.

Based on Brevan Howard Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.